Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction Chemotherapy for Cyclin D1 High cN2 OSCC
NCT02290145Phase 2Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2016
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in oral squamous cell carcinoma (OSCC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Dec 2016; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT02290145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290145.